Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 158

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 158
---
NLS’s patents could irretrievably lapse due to failure to pay fees or otherwise comply with regulations, or could be subject to compulsory licensing; and •if NLS encounter delays in its development or clinical trials, the period of time during which it could market our products under patent protection would be reduced. Obtaining and maintaining its patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and its patent protection could be reduced or eliminated for noncompliance with these requirements. Periodic maintenance fees on any issued patent are due to be paid to the U.S. PTO and foreign patent agencies in several stages over the term of the patent. The U.S. PTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to office actions within prescribed time limits, non -paymentof fees and failure to properly legalize and submit formal documents. In such an event, its competitors might be able to enter the market, which would have a material adverse effect on its business. NLS may not be able to enforce its intellectual property rights throughout the world. Filing, prosecuting and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and its intellectual property rights in some countries outside the United States and Switzerland can be less extensive than those in the United States and Switzerland. In addition, the laws of some foreign countries do not protect intellectual property to the same extent as laws in the United States and Switzerland. Consequently, NLS may not be able to seek to prevent third parties from practicing its inventions in all countries outside the United States and Switzerland, or from selling or importing products made using its inventions in and into the United States or other jurisdictions. Competitors, for example, may use its technologies in jurisdictions where NLS has not obtained patents to develop their own products and further, may export otherwise infringing products to territories where NLS has patents, but enforcement is not as strong as that in the United States and Switzerland. Many companies